Divalproex Sodium Delayed-Release Tablets Recalled Due to Presence of Foreign Tablets
Bionpharma Inc. is recalling Divalproex Sodium Delayed-Release Tablets, 500 mg, because some bottles may contain foreign tablets or capsules.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA has classified this as a Class II recall, which involves a situation where the probability of adverse health consequences is remote.
Plain-English summary
Bionpharma Inc. is recalling Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, in 500-tablet bottles (Lot# 704C003, Exp. 12/31/2028) due to the presence of foreign tablets or capsules in some bottles.
This recall affects Divalproex Sodium Delayed-Release Tablets, 500 mg, distributed nationwide in the United States. The affected product is identified by NDC 69452-435-30.
Consumers should contact their pharmacist or the manufacturer to discuss the return or replacement of the affected medication.
The recalled product
- Product
- DIVALPROEX SODIUM (DIVALPROEX SODIUM)
- Brand
- DIVALPROEX SODIUM
- Manufacturer
- Bionpharma Inc.
- Category
- Drug — Prescription Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# 704C003
- Exp. 12/31/2028
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · DIVALPROEX SODIUM
- HighDivalproex Sodium 250 mg tablets recalled for failed dissolution specifications
FDA (Drugs) · 2024-04-03
- HighDivalproex Sodium Extended-Release Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2022-08-31
- HighFDA Recalls Divalproex Sodium Tablets for Failed Dissolution Specifications
FDA (Drugs) · 2022-08-03
- ModerateMajor Pharmaceuticals Recalls Divalproex Sodium Tablets Due to Humidity Exposure
FDA (Drugs) · 2019-08-07
- HighDr. Reddy's Recalls Divalproex Sodium Tablets for Dissolution Failure
FDA (Drugs) · 2019-02-27
Same manufacturer · Bionpharma Inc.
See all →- SevereAtovaquone Oral Suspension Recalled for Cohnella Bacteria Contamination
FDA (Drugs) · 2024-10-23
- SevereBionpharma Recalls Clobazam Oral Suspension Due to Microbial Contamination
FDA (Drugs) · 2019-07-31
Same hazard · foreign matter
See all →- SevereSpectra Medical Devices Recalls Sodium Chloride Injection Ampules Due to Sterility Concerns
FDA (Devices) · 2026-08-19
- HighLidocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModeratePasteurized donor human milk bottles show dark spot contamination
FDA (Food) · 2026-06-17
- ModerateVitamin B-Complex and Vitamin C Dietary Supplement Recalled for Foreign Matter
FDA (Food) · 2026-05-27
- HighAvitene Ultrafoam Microfibrillar Collagen Hemostat Recalled for Foreign Matter
FDA (Devices) · 2026-04-29